跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Inlyta - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Inlyta
Approved
STANDARD
Inlyta
Pfizer Manufacturing Deutschland GmbH
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
860b054b5ebe8a8b
Company
Pfizer Manufacturing Deutschland GmbH
Type
Standard
Approval Details
Approval Id
860b054b5ebe8a8b
Drug Approval Philippines Name
Inlyta
Product Name
Inlyta
Registration Number
DR-XY43764
Brand Name
Inlyta
Generic Name
Axitinib
Dosage Form
Film-Coated Tablet `
Dosage Strength
5 mg
Manufacturer
Pfizer Manufacturing Deutschland GmbH
Importer
Pfizer, Inc.
Company Detail Path
/organization/pfizer-manufacturing-deutschland-gmbh
Importer Detail Path
/organization/pfizer-inc-pleasant-prairie-wisconsin-united-states
Issuance Date
28 August 2024
Expiry Date
02 October 2029
Pharmacologic Category
Tyrosine Kinase Inhibitor
Classification
Prescription (Rx) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
860b054b5ebe8a8b
Type
Standard
Back to Philippines FDA Approvals